COVID-19 patients: baseline characteristics, type of symptoms and length of stay
| Phase 1 (n=85) | Phase 2 (n=99) | Total (n=184) | P value | |
| Females, n (%) | 20 (23.5) | 27 (27.3) | 47 (25.5) | 0.56 |
| Age, median (IQR) Age ≥75 years, n (%) | 68 (59–77) 25 (29.4) | 71 (60–80) 38 (38.4) | 69 (59–79) 63 (34.2) | 0.31 0.20 |
| With symptoms, n (%) pneumonia fever | 75 (88.2) 67 (89.3) 48 (64.0) | 45 (45.5) 33 (73.3) 24 (53.3) | 120 (65.2) 100 (83.3) 72 (60.0) | <0.0001 0.02 0.25 |
| Assisted ventilation, n (%) O2 Therapy, n (%) CPAP, n (%) Intubation, n (%) | 67 (78.8) 43 (64.2) 29 (43.3) 11.9 | 43 (43.4) 40 (93.0) 10 (23.3) 4.7 | 110 (59.8) 83 (75.5) 39 (35.5) 9.1 | <0.0001 0.0006 0.03 0.31 |
| Lenght of in ICC stay Median (IQR) | 4 (3–6) | 4 (2–6) | 4 (3–6) | 0.55 |
| Length of in-hospital stay Median, (IQR) | 12 (7–22) | 7 (4–12) | 9 (6–15) | <0.0001 |
Phase 1 (enrolment between March and April 2020): 30 days for the retrospective phase.
Phase 2 (enrolment between November 2020 and February 2021): 30 days for the prospective phase.
ICC, intensive cardiac care.